The Mauritius-based entity acquired Emcure Pharmaceuticals through a block deal worth Rs. 289 crore worth of shares sold; Acquiring Norges Bank

Emcure Pharmaceuticals on Wednesday saw a block deal in which Mauritius-based investment entity BC Investments IV Ltd bought Rs. 18 lakh shares were sold in a transaction worth Rs 289 crore.

This share was transferred by Norges Bank from the account of The Government Pension Fund Global for Rs. 1,608.2 were purchased. Shares traded on NSE today at Rs. ended with a strong gain of 8% at 1,729.90.

BC Investments IV, an affiliate of Bain Capital, holds more than 73.39 lakh shares representing 3.87% stake in the company as on March 31, 2026.

The stock has returned 67% in the past 12 months, outperforming the benchmark Nifty and BSE Sensex, which have returned -1% and -3% respectively in the same period.

According to Trendlyne data, the stock is currently trading above its 50-day and 200-day simple moving averages (SMA) of Rs. 1,535 and Rs. 1,438 is trading above.

A pharma company into manufacturing of APIs and formulations.

The company paid Rs. 231 crore as compared to Rs. 154 crore showing a growth of 50 percent. The company paid Rs. 2,365 crore in total revenue as compared to Rs. 1,966 crore showing a 20% year-on-year growth.

Emcure Pharmaceuticals Rs. It is a small cap stock with a market capitalization of Rs 32,742 crore.

Also Read: Rs. See Goldman Sachs, Morgan Stanley, MFs move in Rs 186 crore Delhivery block deal; Nexus sells shares

(Disclaimer: Recommendations, suggestions, opinions and views given by experts are their own. These do not represent the views of Economic Times.)